|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.64 USD | -1.50% |
|
+2.26% | +168.37% |
Chart calendar BridgeBio Pharma, Inc.
Upcoming events on BridgeBio Pharma, Inc.
| 2026-02-18 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-04-29 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-07-29 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-10-28 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on BridgeBio Pharma, Inc.
| 2025-12-03 | Evercore Healthcare Conference |
| 2025-12-02 | Piper Sandler Healthcare Conference |
| 2025-11-18 | Jefferies Global Healthcare Conference |
| 2025-11-10 | UBS Global Healthcare Conference |
| 2025-10-29 | Q3 2025 Earnings Call |
| 2025-10-29 | Q3 2025 Earnings Release |
| 2025-10-29 | Autosomial Dominant Hypocalcemia Type 1 (ADH1) CALIBRATE Phase 3 Topline Results Call |
| 2025-10-27 | LGMD2I/R9 Fortify Phase 3 Interim Analysis Topline Results Call |
| 2025-09-28 | Heart Failure Society of America Scientific Meeting |
| 2025-09-28 | Heart Failure Society of America Scientific Meeting |
| 2025-09-27 | Heart Failure Society of America Scientific Meeting |
| 2025-09-27 | Heart Failure Society of America Scientific Meeting |
| 2025-09-27 | Heart Failure Society of America Scientific Meeting |
| 2025-09-10 | Investor Meeting |
| 2025-09-08 | Morgan Stanley Global Healthcare Conference |
| 2025-09-06 | American Society for Bone and Mineral Research Meeting - Bhavik Shah, Ph.D |
| 2025-09-06 | American Society for Bone and Mineral Research Meeting - Iris Hartley, M.D |
| 2025-09-05 | American Society for Bone and Mineral Research Meeting - Skeletal Dysplasia |
| 2025-09-04 | Cantor Global Healthcare Conference |
| 2025-09-03 | Wells Fargo Healthcare Conference |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 77,6 80,3 -3.36% | 9,30 11,3 -17.31% | 222 282 -21.24% | 495 | 889 | 1 492 |
|
EBITDA Million USD | Released Forecast Spread | -505 -500 -1.16% | -593 -535 -10.93% | -587 -549 -6.86% | -489 | -281 | 25,4 |
|
EBIT Million USD | Released Forecast Spread | -512 -499 -2.64% | -607 -568 -6.87% | -593 -560 -5.86% | -503 | -269 | 177 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -485 -469 -3.32% | -653 -635 -2.82% | -542 -481 -12.72% | -688 | -346 | 79,1 |
|
Net income Million USD | Released Forecast Spread | -481 -477 -0.79% | -643 -624 -3.05% | -536 -441 -21.55% | -680 | -357 | 68,4 |
|
EPS USD | Released Forecast Spread | -3,26 -3,21 -1.52% | -3,95 -3,87 -2.15% | -2,88 -2,44 -18.2% | -3,44 | -1,71 | 0,44 |
| Announcement Date | 23/02/23 | 22/02/24 | 20/02/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 211 83,8 152% | 2,17 4,48 -51.55% | 2,73 3,38 -19.2% | 5,88 4,04 45.62% | 117 57,7 102.06% | 111 88,8 24.54% | 121 106 13.78% | 148 | 170 | 196 | 225 | 272 |
|
EBITDA Million USD | Released Forecast Spread | 27,8 -143 119.49% | -171 -141 -20.92% | -186 -148 -25.51% | -103 -219 53.03% | -132 -121 -9.63% | -135 -137 1.33% | -94,5 | -61,0 | -39,0 | -37,8 | ||
|
EBIT Million USD | Released Forecast Spread | 0,34 -117 100.29% | -176 -187 6.18% | -192 -179 -7.13% | -226 -193 -17.28% | -104 -157 33.54% | -134 -139 3.19% | -145 -146 0.71% | -117 | -97,0 | -77,1 | -57,9 | -20,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -36,2 -99,7 63.75% | -75,5 -209 63.94% | -164 -197 16.78% | -266 -200 -33.25% | -170 -181 6.33% | -182 -167 -8.59% | -186 -176 -6.21% | -145 | -129 | -110 | -89,3 | -49,1 |
|
Net income Million USD | Released Forecast Spread | -35,2 -122 71.14% | -73,5 -192 61.77% | -162 -196 17.38% | -265 -202 -31.29% | -167 -164 -1.91% | -182 -163 -11.47% | -183 -175 -4.36% | -148 | -128 | -109 | -89,8 | -54,2 |
|
EPS USD | Released Forecast Spread | -0,20 -0,51 60.72% | -0,39 -1,06 63.08% | -0,86 -0,95 9.83% | -1,40 -0,95 -48.14% | -0,88 -0,93 5.79% | -0,95 -0,84 -13.17% | -0,95 -0,89 -6.71% | -0,66 | -0,65 | -0,55 | -0,45 | -0,24 |
| Announcement Date | 02/05/24 | 01/08/24 | 12/11/24 | 20/02/25 | 29/04/25 | 05/08/25 | 29/10/25 | - | - | - | - | - |
| 2026-01-27 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-28 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-29 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-29 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-04 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-04 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-05 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-02-09 | Q2 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-02-11 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-12 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
Past sector events for BridgeBio Pharma, Inc.
| 2025-11-14 | Q4 2025 Earnings Release | |
| 2025-11-14 | Q3 2025 Earnings Release | |
| 2025-11-13 | Q3 2025 Earnings Release | |
| 2025-11-13 | Q3 2025 Earnings Release | |
| 2025-11-13 | Q3 2025 Earnings Release | |
| 2025-11-13 | Q2 2026 Earnings Release | |
| 2025-11-12 | Q3 2025 Earnings Release | |
| 2025-11-12 | Q3 2025 Earnings Release | |
| 2025-11-10 | Q3 2025 Earnings Release | |
| 2025-11-10 | October 2025 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BBIO Stock
- Calendar BridgeBio Pharma, Inc.
Select your edition
All financial news and data tailored to specific country editions
















